Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-K stay in one workspace.
PTHS
$20.35
-3.14%
PTHS
· Pelthos Therapeutics Inc.
$20.35
-0.66 (-3.14%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“in prior periods, management disclosed substantial doubt about the Company's ability to continue as a going concern. The conditions and events that previously raised substantial doubt have been alleviated by management's plans and actions.”View the 10-Q filed May 14, 2026
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 1
44.59K
Avg daily vol (3M)
58.45K
All webcasts
Earnings call · FY2025 Q4
Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$9.39M
Net income · derived Q4
-$21.66M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 19, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 19, 2026 · complete as-filed document